
| 5 min read
FDA pilot programs, aging discoveries, and diagnostic advances led the week’s headlines. 
| 4 min read
Neflamapimod shows promise in slowing ALS by targeting protein clumps and restoring nerve cell function.
| 3 min read
A new biological foundation model analyzes genomic patterns across the tree of life and may accelerate disease research and synthetic biology.
| 4 min read
Wake Forest researchers have reprogrammed macrophages to target metastatic tumors in the brain, offering a potential new approach where conventional therapies struggle.News
Cancer Research News
Emerging clinical trials suggest that the gut microbiome plays a decisive role in how patients respond to immunotherapy.
Live-cell assays quantify the genetic and metabolic influence on drug selectivity, enabling the development of more precise cancer therapies.
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
Explore the scientific advances driving more specific, potent, and adaptable antibody-based therapies.
Explore how breakthroughs in fast confocal imaging and 3D cell culture converged to transform the study of complex human biology in vitro.



















